Assessing the pharmacokinetics of Ampicillin in newborns' umbilical cord blood and plasma after intrapartum administration for preventing early onset group B streptococcal infection (A prospective study)

Clin Ter. 2025;176(3):358-362. doi: 10.7417/CT.2025.5234.

Abstract

Objective: The purpose of this study is to determine whether or not ampicillin, following a standard prophylactic dose against group B streptococcal infection, reaches concentrations above the minimum inhibitory concentrations (MIC) in maternal plasma and umbilical cord blood (UCB).

Patients and methods: From January 2024 to December 2024, this prospective study was conducted at Al-Azhar and Helwan University Hospitals and included 200 newborns whose moms had received intrapartum ampicillin. There were 200 maternal plasma samples and 200 UCB samples available for examination (between 5 and 75 minutes postpartum).

Results: As fast as five minutes after ampicillin infusion, the mean ampicillin concentrations found in maternal and umbilical cord sera all surpassed the lowest bactericidal values documented for group B streptococci (0.25 to 2.0 micrograms/ml).

Conclusion: Neonatal quantities of ampicillin over the MIC of GBS are the result of intrapartum dosing.

Keywords: GBS prophylaxis; ampicillin; pharmaco-kinetics; prophylaxis.

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Ampicillin* / administration & dosage
  • Ampicillin* / blood
  • Ampicillin* / pharmacokinetics
  • Ampicillin* / therapeutic use
  • Anti-Bacterial Agents* / administration & dosage
  • Anti-Bacterial Agents* / blood
  • Anti-Bacterial Agents* / pharmacokinetics
  • Anti-Bacterial Agents* / therapeutic use
  • Antibiotic Prophylaxis*
  • Female
  • Fetal Blood* / chemistry
  • Humans
  • Infant, Newborn
  • Microbial Sensitivity Tests
  • Pregnancy
  • Pregnancy Complications, Infectious / prevention & control
  • Prospective Studies
  • Streptococcal Infections* / prevention & control
  • Streptococcus agalactiae* / drug effects

Substances

  • Ampicillin
  • Anti-Bacterial Agents